Daunorubicin, cytosine arabinoside and 6-thioguanine (DAT) combination chemotherapy for the treatment of acute non-lymphocytic leukemia

Leuk Res. 1979;3(3):147-52. doi: 10.1016/0145-2126(79)90012-2.
No abstract available

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Child
  • Child, Preschool
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Daunorubicin / administration & dosage
  • Daunorubicin / adverse effects
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Leukemia / drug therapy*
  • Leukemia / mortality
  • Male
  • Middle Aged
  • Thioguanine / administration & dosage
  • Thioguanine / adverse effects

Substances

  • Antineoplastic Agents
  • Cytarabine
  • Thioguanine
  • Daunorubicin